المؤلفون: Hughes, Gareth, Dark, Paul

المصدر: RECOVERY Collaborative Group , Hughes , G & Dark , P 2024 , ' Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY) : a randomised, controlled, open-label, platform trial ' , The Lancet. Child & adolescent health , vol. 8 , no. 3 , pp. 190-200 . https://doi.org/10.1016/S2352-4642Test(23)00316-4

مصطلحات موضوعية: Humans, Male, Child, Female, COVID-19/complications, SARS-CoV-2, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Immunoglobulins, Intravenous/therapeutic use, Bayes Theorem, Treatment Outcome, Methylprednisolone/therapeutic use, Inflammation, Immunomodulation, Systemic Inflammatory Response Syndrome

العلاقة: https://research.manchester.ac.uk/en/publications/4c324435-1ff8-4b23-b729-558db148d055Test

الإتاحة: https://doi.org/10.1016/S2352-4642Test(23)00316-4
https://research.manchester.ac.uk/en/publications/4c324435-1ff8-4b23-b729-558db148d055Test

المؤلفون: Ludwig, Heinz, Terpos, Evangelos, van de Donk, Niels, Mateos, Maria-Victoria, Moreau, Philippe, Dimopoulos, Melitios-Athanasios, Delforge, Michel, Rodriguez-Otero, Paula, San-Miguel, Jesús, Yong, Kwee, Gay, Francesca, Einsele, Hermann, Mina, Roberto, Caers, Jo, Driessen, Christoph, Musto, Pellegrino, Zweegman, Sonja, Engelhardt, Monika, Cook, Gordon, Weisel, Katja, Broijl, Annemiek, Beksac, Meral, Bila, Jelena, Schjesvold, Fredrik, Cavo, Michele, Hajek, Roman, Touzeau, Cyrille, Boccadoro, Mario, Sonneveld, Pieter

المصدر: The Lancet Oncology, 24 (6), e255 - e269 (2023-06)

مصطلحات موضوعية: cell-associated neurotoxicity, Antibodies, Bispecific, Interleukin 1 Receptor Antagonist Protein, Humans, Cytokine Release Syndrome/etiology, Cytokine Release Syndrome/prevention & control, Cytokine Release Syndrome/drug therapy, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Consensus, Immunotherapy, Adoptive/adverse effects, T-Lymphocytes, Multiple Myeloma/drug therapy, Antibodies, Bispecific/adverse effects, Cytokine Release Syndrome, Immunotherapy, Adoptive, Multiple Myeloma, Oncology, Human health sciences, Hematology, Sciences de la santé humaine, Hématologie

العلاقة: https://api.elsevier.com/content/article/PII:S1470204523001596?httpAccept=text/xmlTest; urn:issn:1470-2045; urn:issn:1474-5488

الوصول الحر: https://orbi.uliege.be/handle/2268/310482Test

المؤلفون: Audemard-Verger, Alexandra, Le Gouge, Amélie, Pestre, Vincent, Courjon, Johan, Langlois, Vincent, Vareil, Marc-Olivier, Devaux, Mathilde, Bienvenu, Boris, Leroy, Vincent, Goulabchand, Radjiv, Colombain, Léa, Bigot, Adrien, Guimard, Thomas, Douadi, Youcef, Urbanski, Geoffrey, Faucher, Jean-François, Maulin, Laurence, Lioger, Bertrand, Talarmin, Jean-Philippe, Groh, Matthieu, Emmerich, Joseph, Deriaz, Sophie, Ferreira-Maldent, Nicole, Cook, Ann-Rose, Lengellé, Céline, Bourgoin, Hélène, Mékinian, Arsène, Aouba, Achille, Maillot, François, Caille, Agnès

المساهمون: Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Université de Tours (UT), Centre d’Investigation Clinique Tours CIC 1415 (CIC ), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours)-Hôpital Bretonneau-Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Henri Duffaut (Avignon), Service d'infectiologie CHU Nice, Centre Hospitalier Universitaire de Nice (CHU Nice), Groupe Hospitalier du Havre Hôpital Jacques Monod (MONTIVILLIERS) (GHH), Centre Hospitalier de la Côte Basque (CHCB), Centre hospitalier intercommunal de Poissy/Saint-Germain-en-Laye - CHIPS Poissy, Hôpital Saint-Joseph Marseille, Clinique Teissier (Valenciennes) (AHNAC), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Service des Maladies Infectieuses et Tropicales, Centre Hospitalier de Perpignan, Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon (CHD Vendée), Centre hospitalier de Saint-Quentin, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Service des Maladies infectieuses et tropicales CHU Limoges, CHU Limoges, Epidémiologie des Maladies Chroniques en zone tropicale (EpiMaCT), CHU Limoges-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Institut National de la Santé et de la Recherche Médicale (INSERM)-OmégaHealth (ΩHealth), Université de Limoges (UNILIM)-Université de Limoges (UNILIM), CH du Pays d'Aix, Aix-en-Provence, Centre Hospitalier de Blois (CHB), CH de Quimper, Hôpital Foch Suresnes, Groupe Hospitalier Paris Saint-Joseph (hpsj), Centre for Research in Epidemiology and Statistics, Conservatoire National des Arts et Métiers CNAM (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Département de Pharmacologie CHRU Tours, CHU Saint-Antoine AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)

المصدر: ISSN: 1932-6203.

مصطلحات موضوعية: MESH: Adult, MESH: COVID-19 Drug Treatment, MESH: Humans, MESH: Interleukin 1 Receptor Antagonist Protein / adverse effects, MESH: Interleukin 1 Receptor Antagonist Protein / therapeutic use, MESH: Respiration, Artificial, MESH: SARS-CoV-2, MESH: Treatment Outcome, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie

العلاقة: hal-04064443; https://hal.science/hal-04064443Test; https://hal.science/hal-04064443/documentTest; https://hal.science/hal-04064443/file/journal.pone.0269065.pdfTest

الإتاحة: https://doi.org/10.1371/journal.pone.0269065Test
https://hal.science/hal-04064443Test
https://hal.science/hal-04064443/documentTest
https://hal.science/hal-04064443/file/journal.pone.0269065.pdfTest

المؤلفون: Durdzińska Timóteo, A., Dumusc, A., Durand, S.

المصدر: Hand surgery & rehabilitation, vol. 41, no. 6, pp. 701-706

مصطلحات موضوعية: Humans, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Wrist, Calcium, Retrospective Studies, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Pain, Anakinra, Basic calcium phosphate, Blocage IL-1, Calcific periarthritis, Hand, IL-1 blockade, Main, Phosphate de calcium basique, Périarthrite calcifiante, Ultrasons, Ultrasound

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36087874; info:eu-repo/semantics/altIdentifier/eissn/2468-1210; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_437E3B239CC31; https://serval.unil.ch/notice/serval:BIB_437E3B239CC3Test; urn:issn:2468-1210; https://serval.unil.ch/resource/serval:BIB_437E3B239CC3.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_437E3B239CC31Test

الإتاحة: https://doi.org/10.1016/j.hansur.2022.08.009Test
https://serval.unil.ch/notice/serval:BIB_437E3B239CC3Test
https://serval.unil.ch/resource/serval:BIB_437E3B239CC3.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_437E3B239CC31Test

المؤلفون: Mikkelsen, Rasmus R, Hundahl, Malthe P, Torp, Christopher K, Rodríguez-Carrio, Javier, Kjolby, Mads, Bruun, Jens M, Kragstrup, Tue W

المصدر: Mikkelsen , R R , Hundahl , M P , Torp , C K , Rodríguez-Carrio , J , Kjolby , M , Bruun , J M & Kragstrup , T W 2022 , ' Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus : A bedside-to-bench approach ' , European Journal of Pharmacology , vol. 925 , 174998 . https://doi.org/10.1016/j.ejphar.2022.174998Test

مصطلحات موضوعية: Animals, Cardiovascular Diseases/drug therapy, Colchicine, Diabetes Mellitus, Type 2/complications, Etanercept/pharmacology, Humans, Hydroxychloroquine/therapeutic use, Immunosuppression Therapy, Inflammation/chemically induced, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Methotrexate/therapeutic use, Sulfasalazine/therapeutic use, Hydroxychloroquine/pharmacology, Immunomodulating Agents/pharmacology, Sulfasalazine/pharmacology, Colchicine/pharmacology, Interleukin-1/antagonists & inhibitors, Type 2/drug therapy, Interleukin 1 Receptor Antagonist Protein/pharmacology, Interleukin-1beta/antagonists & inhibitors, Antibodies, Monoclonal, Humanized/pharmacology, Immunosuppressive Agents/pharmacology, Inflammation/drug therapy, Methotrexate/pharmacology

وصف الملف: application/pdf

العلاقة: https://pure.au.dk/portal/da/publications/immunomodulatory-and-immunosuppressive-therapies-in-cardiovascular-disease-and-type-2-diabetes-mellitusTest(89dc7ad3-f029-46e6-b0e6-b29b06deb44c).html

الإتاحة: https://doi.org/10.1016/j.ejphar.2022.174998Test
https://pure.au.dk/portal/da/publications/immunomodulatory-and-immunosuppressive-therapies-in-cardiovascular-disease-and-type-2-diabetes-mellitusTest(89dc7ad3-f029-46e6-b0e6-b29b06deb44c).html
https://pure.au.dk/ws/files/352590179Test/1-s2.0-S001429992200259X-main.pdf

المساهمون: Jae Seok Kim, Jun Young Lee, Jae Won Yang, Keum Hwa Lee, Maria Effenberger, Wladimir Szpirt, Andreas Kronbichler, Jae Il Shin, Shin, Jae Il

مصطلحات موضوعية: Anti-Inflammatory Agents / pharmacology, Anti-Inflammatory Agents / therapeutic use, Antibodies, Monoclonal, Humanized / pharmacology, Humanized / therapeutic use, Azetidines / pharmacology, Azetidines / therapeutic use, COVID-19 / complications, COVID-19 / drug therapy, COVID-19 / immunology, COVID-19 / virology, Clinical Trials as Topic, Cytokine Release Syndrome / drug therapy, Cytokine Release Syndrome / immunology, Cytokines / antagonists & inhibitors, Cytokines / immunology, Cytokines / metabolism, Humans, Immunosuppressive Agents / pharmacology, Immunosuppressive Agents / therapeutic use, Interleukin 1 Receptor Antagonist Protein / pharmacology, Interleukin 1 Receptor Antagonist Protein / therapeutic use, Janus Kinases / antagonists & inhibitors, Janus Kinases / metabolism, Purines / pharmacology, Purines / therapeutic use, Pyrazoles / pharmacology, Pyrazoles / therapeutic use, SARS-CoV-2 / immunology

العلاقة: THERANOSTICS; J03103; OAK-2021-01759; https://ir.ymlib.yonsei.ac.kr/handle/22282913/181964Test; T202100024; THERANOSTICS, Vol.11(1) : 316-329, 2021-01

الإتاحة: https://doi.org/10.7150/thno.49713Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/181964Test

المؤلفون: Liu, Johnson M, Chi, Jeffrey

المصدر: Maine Medical Center

مصطلحات موضوعية: COVID-19, Cytokines, hemophagocytic lymphohistiocytosis, immunobiology, immunology/microbiology/virology, inflammation, Antibodies, Monoclonal (therapeutic use), Neutralizing (therapeutic use), COVID-19 (complications), Cytokine Release Syndrome (etiology, therapy, virology), Humans, Interleukin 1 Receptor Antagonist Protein (therapeutic use), Lymphohistiocytosis, Hemophagocytic (diagnosis, etiology, immunology, therapy)

العلاقة: https://knowledgeconnection.mainehealth.org/mmc/2223Test; https://pubmed.ncbi.nlm.nih.gov/35068219Test/

الإتاحة: https://knowledgeconnection.mainehealth.org/mmc/2223Test
https://pubmed.ncbi.nlm.nih.gov/35068219Test/

المؤلفون: Rasmus R. Mikkelsen, Malthe P. Hundahl, Christopher K. Torp, Javier Rodríguez-Carrio, Mads Kjolby, Jens M. Bruun, Tue W. Kragstrup

المصدر: Scopus
Mikkelsen, R R, Hundahl, M P, Torp, C K, Rodríguez-Carrio, J, Kjolby, M, Bruun, J M & Kragstrup, T W 2022, ' Immunomodulatory and immunosuppressive therapies in cardiovascular disease and type 2 diabetes mellitus : A bedside-to-bench approach ', European Journal of Pharmacology, vol. 925, 174998 . https://doi.org/10.1016/j.ejphar.2022.174998Test

مصطلحات موضوعية: Inflammation/chemically induced, Methotrexate/therapeutic use, Sulfasalazine/therapeutic use, Interleukin-1beta, Antibodies, Monoclonal, Humanized, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Etanercept, Immunomodulating Agents, Animals, Humans, Immunosuppression Therapy, Inflammation, Pharmacology, Diabetes Mellitus, Type 2/complications, Etanercept/pharmacology, Sulfasalazine, Interleukin 1 Receptor Antagonist Protein, Methotrexate, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Hydroxychloroquine/therapeutic use, Cardiovascular Diseases/drug therapy, Colchicine, Immunosuppressive Agents, Hydroxychloroquine, Interleukin-1

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f756fa0c7d520da4cd8a98288ea820dTest
http://hdl.handle.net/10651/65535Test

المؤلفون: Caroline Vinit, Sophie Georgin-Lavialle, Aikaterini Theodoropoulou, Catherine Barbier, Alexandre Belot, Manel Mejbri, Pascal Pillet, Jana Pachlopnik, Sylvaine Poignant, Charlotte Rebelle, Andreas Woerner, Isabelle Koné-Paut, Véronique Hentgen

المساهمون: Centre Hospitalier de Versailles André Mignot (CHV), Service de Médecine Interne [CHU Tenon], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Lausanne University Hospital, Centre Hospitalier Universitaire [Grenoble] (CHU), Service de néphrologie, rhumatologie et dermatologie pédiatriques [Hôpital Femme Mère Enfant, HCL], Hospices Civils de Lyon (HCL)-Hôpital Mère Enfant, CHU Bordeaux [Bordeaux], Département de pédiatrie [CHU Nantes], Centre hospitalier universitaire de Nantes (CHU Nantes), CHU de Bordeaux Pellegrin [Bordeaux], University Children’s Hospital Basel = Hôpital pédiatrique universitaire des deux Bâle [Bâle, Suisse] (UKBB), Service de Rhumatologie [CHU Bicêtre], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Bicêtre

المصدر: Frontiers in Immunology, Vol 12 (2021)
Frontiers in immunology, vol. 12, pp. 744780
Frontiers in Immunology
Frontiers in Immunology, Frontiers, 2021, 12, ⟨10.3389/fimmu.2021.744780⟩

مصطلحات موضوعية: Male, Familial Mediterranean fever, interleukin-1 blockers, Adolescent, Adult, Aged, Antibodies, Monoclonal, Humanized/therapeutic use, Antirheumatic Agents/therapeutic use, Child, Child, Preschool, Female, Hereditary Autoinflammatory Diseases/complications, Hereditary Autoinflammatory Diseases/drug therapy, Humans, Infant, Interleukin 1 Receptor Antagonist Protein/therapeutic use, Interleukin-1/antagonists & inhibitors, Middle Aged, Retrospective Studies, Young Adult, anakinra, autoinflammatory diseases, canakinumab, hereditary recurrent fevers, indications, treatment, 0302 clinical medicine, Quality of life, Immunology and Allergy, Original Research, 0303 health sciences, Mevalonate kinase deficiency, Interleukin, 3. Good health, Antirheumatic Agents, [SDV.IMM]Life Sciences [q-bio]/Immunology, medicine.drug, medicine.medical_specialty, Immunology, MEDLINE, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Internal medicine, medicine, 030304 developmental biology, 030203 arthritis & rheumatology, Anakinra, business.industry, Hereditary Autoinflammatory Diseases, RC581-607, medicine.disease, Canakinumab, Interleukin 1 Receptor Antagonist Protein, Immunologic diseases. Allergy, Complication, business, Interleukin-1

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e625e3774c42c4cbcb268ba3e8a594dTest
https://www.frontiersin.org/articles/10.3389/fimmu.2021.744780/fullTest

المؤلفون: Idorn, Lars, Vissing, Nadja Hawwa, Jensen, Lise, Herlin, Troels

المصدر: Ugeskrift for Laeger. 174(22):1537